Skip to content
Parakho

Q1 FY27, unaudited

Revenue
₹87.65 Cr
Profit after tax
₹12.85 Cr

As filed with the exchange, consolidated basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, consolidated basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations87.65+20.75%310.41
Other income1.09+20.09%3.16
Total income88.73+20.74%313.58
Employee benefit expense14.41+12.82%53.26
Finance costs3.72+37.61%12.55
Depreciation & amortisation11.28+18.98%41.45
Total expenses72.21+18.33%269.02
Profit before tax16.53+32.54%44.56
Tax expense3.68+11.74%13.15
Profit after tax12.85+40.00%31.40
Total comprehensive income12.99+38.61%31.97
Earnings per share
Earnings per share, basic₹2.50₹6.18
Earnings per share, diluted₹2.50₹6.18

Q1 FY27 unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base unaudited, from the company’s filing with NSE. Source

FY26 from the company’s filing with NSE. Source

Earnings call

Q4 FY26

Suraksha Diagnostic reported FY26 revenue from operations of INR3104.1 million, up 23.1% year-on-year, with blended EBITDA margin of 31.73% and PAT of INR314 million. Management said the year included expansion into 68 centers with new hub and spoke launches, alongside investments in genomics, molecular diagnostics and MRI technology. For FY27, management outlined plans to add hubs and spokes in West Bengal and expand into Bihar, Tripura and Jharkhand, while flagging near-term margin pressure from new center ramp-up costs.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary

Filings

12 shown · 32 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 25 Aug 2026.

Suraksha Diagnostic Ltd (SURAKSHA) — filings and results · Parakho